nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—Bopindolol—HTR1B—attention deficit hyperactivity disorder	0.018	0.379	CrCbGaD
Ketoprofen—CXCL8—midbrain—attention deficit hyperactivity disorder	0.0117	0.0767	CbGeAlD
Ketoprofen—CXCL8—cerebellum—attention deficit hyperactivity disorder	0.00901	0.0593	CbGeAlD
Ketoprofen—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.00864	0.0569	CbGeAlD
Ketoprofen—ABCC4—forebrain—attention deficit hyperactivity disorder	0.00831	0.0547	CbGeAlD
Ketoprofen—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.00746	0.157	CrCbGaD
Ketoprofen—CXCL8—brain—attention deficit hyperactivity disorder	0.00732	0.0482	CbGeAlD
Ketoprofen—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.00711	0.15	CrCbGaD
Ketoprofen—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.00642	0.135	CrCbGaD
Ketoprofen—SLC22A7—brain—attention deficit hyperactivity disorder	0.00592	0.039	CbGeAlD
Ketoprofen—SLC22A6—brain—attention deficit hyperactivity disorder	0.00572	0.0376	CbGeAlD
Ketoprofen—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.0057	0.0376	CbGeAlD
Ketoprofen—CXCL8—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00518	0.00647	CbGpPWpGaD
Ketoprofen—SLC22A6—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0051	0.00637	CbGpPWpGaD
Ketoprofen—PTGS1—forebrain—attention deficit hyperactivity disorder	0.00489	0.0322	CbGeAlD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00489	0.0061	CbGpPWpGaD
Ketoprofen—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.0048	0.101	CrCbGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00473	0.0059	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00472	0.0059	CbGpPWpGaD
Ketoprofen—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.00469	0.0309	CbGeAlD
Ketoprofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00468	0.00584	CbGpPWpGaD
Ketoprofen—PTGS2—forebrain—attention deficit hyperactivity disorder	0.00468	0.0308	CbGeAlD
Ketoprofen—CXCR1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00457	0.00571	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00456	0.0057	CbGpPWpGaD
Ketoprofen—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00453	0.0298	CbGeAlD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—attention deficit hyperactivity disorder	0.00452	0.00564	CbGpPWpGaD
Ketoprofen—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.00451	0.0297	CbGeAlD
Ketoprofen—ABCC4—nervous system—attention deficit hyperactivity disorder	0.00451	0.0297	CbGeAlD
Ketoprofen—SLC22A8—nervous system—attention deficit hyperactivity disorder	0.00448	0.0295	CbGeAlD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00447	0.00558	CbGpPWpGaD
Ketoprofen—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.00441	0.0291	CbGeAlD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00439	0.00549	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00439	0.00549	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00435	0.00543	CbGpPWpGaD
Ketoprofen—ABCC4—central nervous system—attention deficit hyperactivity disorder	0.00434	0.0286	CbGeAlD
Ketoprofen—SLC22A8—central nervous system—attention deficit hyperactivity disorder	0.00431	0.0284	CbGeAlD
Ketoprofen—CXCR1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00426	0.00532	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00425	0.00531	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.00419	0.00523	CbGpPWpGaD
Ketoprofen—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.00414	0.0272	CbGeAlD
Ketoprofen—CXCR1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00411	0.00514	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00407	0.00508	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00404	0.00505	CbGpPWpGaD
Ketoprofen—CXCR1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00399	0.00499	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00399	0.00499	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00399	0.00498	CbGpPWpGaD
Ketoprofen—PTGS2—cardiovascular system—attention deficit hyperactivity disorder	0.00396	0.026	CbGeAlD
Ketoprofen—CXCR1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00395	0.00493	CbGpPWpGaD
Ketoprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00391	0.00488	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.0039	0.00487	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00388	0.00485	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00387	0.00483	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00372	0.00465	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00369	0.00461	CbGpPWpGaD
Ketoprofen—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.00369	0.0777	CrCbGaD
Ketoprofen—ABCC4—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00363	0.00453	CbGpPWpGaD
Ketoprofen—SLCO1A2—brain—attention deficit hyperactivity disorder	0.00358	0.0236	CbGeAlD
Ketoprofen—ALB—brain—attention deficit hyperactivity disorder	0.00356	0.0235	CbGeAlD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00352	0.0044	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00348	0.00435	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00347	0.00434	CbGpPWpGaD
Ketoprofen—ABCC4—brain—attention deficit hyperactivity disorder	0.00345	0.0227	CbGeAlD
Ketoprofen—SLC22A8—brain—attention deficit hyperactivity disorder	0.00342	0.0225	CbGeAlD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00342	0.00427	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00341	0.00425	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0034	0.00425	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00331	0.00413	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00323	0.00404	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00319	0.00398	CbGpPWpGaD
Ketoprofen—PTGS1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00318	0.00397	CbGpPWpGaD
Ketoprofen—CXCL8—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00311	0.00388	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0031	0.00388	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0031	0.00387	CbGpPWpGaD
Ketoprofen—PTGS2—midbrain—attention deficit hyperactivity disorder	0.00309	0.0203	CbGeAlD
Ketoprofen—CXCL8—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00307	0.00383	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00301	0.00376	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00298	0.00372	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00298	0.00372	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00296	0.0037	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00295	0.00369	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00293	0.00366	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00284	0.00355	CbGpPWpGaD
Ketoprofen—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00279	0.00348	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00277	0.00346	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00276	0.00344	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00272	0.00339	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00271	0.00339	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00271	0.00338	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.0027	0.00337	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00268	0.00335	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00266	0.00332	CbGpPWpGaD
Ketoprofen—PTGS1—nervous system—attention deficit hyperactivity disorder	0.00266	0.0175	CbGeAlD
Ketoprofen—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00265	0.00331	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00263	0.00328	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00261	0.00325	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00259	0.00324	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00258	0.00322	CbGpPWpGaD
Ketoprofen—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.00256	0.0168	CbGeAlD
Ketoprofen—PTGS2—nervous system—attention deficit hyperactivity disorder	0.00254	0.0167	CbGeAlD
Ketoprofen—SLC22A7—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00253	0.00316	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00252	0.00314	CbGpPWpGaD
Ketoprofen—CYP2C8—brain—attention deficit hyperactivity disorder	0.0025	0.0165	CbGeAlD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00248	0.0031	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00247	0.00309	CbGpPWpGaD
Ketoprofen—PTGS2—central nervous system—attention deficit hyperactivity disorder	0.00244	0.0161	CbGeAlD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00244	0.00305	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—attention deficit hyperactivity disorder	0.00244	0.00304	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00243	0.00304	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.0024	0.003	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0024	0.00299	CbGpPWpGaD
Ketoprofen—PTGS2—cerebellum—attention deficit hyperactivity disorder	0.00239	0.0157	CbGeAlD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—EP300—attention deficit hyperactivity disorder	0.00239	0.00298	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00237	0.00296	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00236	0.00295	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00234	0.00293	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00233	0.00291	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00232	0.0029	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00229	0.00286	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00229	0.00285	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00226	0.00282	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00224	0.0028	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0022	0.00275	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00218	0.00272	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00214	0.00267	CbGpPWpGaD
Ketoprofen—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00213	0.00266	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00211	0.00264	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0021	0.00263	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00208	0.00259	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00206	0.00258	CbGpPWpGaD
Ketoprofen—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00205	0.00256	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00205	0.00256	CbGpPWpGaD
Ketoprofen—PTGS1—brain—attention deficit hyperactivity disorder	0.00203	0.0134	CbGeAlD
Ketoprofen—CXCL8—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00196	0.00245	CbGpPWpGaD
Ketoprofen—PTGS2—brain—attention deficit hyperactivity disorder	0.00194	0.0128	CbGeAlD
Ketoprofen—CXCL8—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00192	0.0024	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00192	0.00239	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00191	0.00238	CbGpPWpGaD
Ketoprofen—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00189	0.00236	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00186	0.00232	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00182	0.00228	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0018	0.00225	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00178	0.00223	CbGpPWpGaD
Ketoprofen—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00177	0.00222	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00175	0.00218	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00175	0.00218	CbGpPWpGaD
Ketoprofen—PTGS1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0017	0.00212	CbGpPWpGaD
Ketoprofen—PTGS1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00169	0.00211	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00168	0.0021	CbGpPWpGaD
Ketoprofen—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00167	0.00209	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00166	0.00208	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00158	0.00198	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00157	0.00196	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00154	0.00193	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00147	0.00184	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00143	0.00178	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00142	0.00177	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00139	0.00173	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00135	0.00168	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00134	0.00167	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00133	0.00167	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00129	0.00161	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00129	0.00161	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00129	0.0016	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00128	0.0016	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00125	0.00156	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00123	0.00153	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00123	0.00153	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00121	0.00151	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00121	0.00151	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00119	0.00148	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00118	0.00147	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00117	0.00146	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00113	0.00141	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00112	0.0014	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.0011	0.00138	CbGpPWpGaD
Ketoprofen—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0011	0.00137	CbGpPWpGaD
Ketoprofen—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00109	0.00136	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00108	0.00135	CbGpPWpGaD
Ketoprofen—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00108	0.00135	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00108	0.00135	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00106	0.00132	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00105	0.00132	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00105	0.00131	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00104	0.00129	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00103	0.00129	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.00129	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.00103	0.00128	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00102	0.00127	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00101	0.00126	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000984	0.00123	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000959	0.0012	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000953	0.00119	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000949	0.00119	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000938	0.00117	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000937	0.00117	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000925	0.00116	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000922	0.00115	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000914	0.00114	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000902	0.00113	CbGpPWpGaD
Ketoprofen—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000893	0.00112	CbGpPWpGaD
Ketoprofen—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000887	0.00111	CbGpPWpGaD
Ketoprofen—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000881	0.0011	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000862	0.00108	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00079	0.000987	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—STUB1—attention deficit hyperactivity disorder	0.000767	0.000958	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000715	0.000893	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000695	0.000868	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000665	0.00083	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000631	0.000788	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000631	0.000788	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000625	0.000781	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00062	0.000775	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000603	0.000754	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000581	0.000726	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000578	0.000722	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000577	0.00072	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000563	0.000703	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000553	0.000691	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000552	0.000689	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000546	0.000682	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000532	0.000665	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000509	0.000636	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000504	0.00063	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00048	0.000599	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00048	0.000599	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00048	0.000599	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000472	0.000589	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000469	0.000585	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000449	0.000561	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000446	0.000558	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000439	0.000548	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000436	0.000545	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000418	0.000523	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000384	0.000479	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000382	0.000477	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000381	0.000476	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000381	0.000476	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000379	0.000474	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000375	0.000468	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000368	0.000459	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000365	0.000456	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000365	0.000456	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000364	0.000454	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000356	0.000445	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000348	0.000435	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00031	0.000387	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00031	0.000387	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000308	0.000385	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000308	0.000385	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000305	0.000381	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000304	0.00038	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000303	0.000379	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000291	0.000363	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00029	0.000362	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000289	0.00036	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000283	0.000354	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000282	0.000352	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00028	0.00035	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000252	0.000315	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000252	0.000315	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000248	0.00031	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000248	0.000309	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000246	0.000308	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000236	0.000295	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000234	0.000293	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000231	0.000288	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000231	0.000288	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000229	0.000286	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000222	0.000277	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000202	0.000252	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000197	0.000247	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000192	0.00024	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000189	0.000236	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000188	0.000234	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	0.000187	0.000233	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000186	0.000233	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000185	0.000232	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000181	0.000226	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00018	0.000225	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000164	0.000205	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000153	0.000191	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000152	0.000189	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000147	0.000184	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000125	0.000156	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EP300—attention deficit hyperactivity disorder	0.000118	0.000148	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—EP300—attention deficit hyperactivity disorder	9.89e-05	0.000124	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	8.05e-05	0.000101	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	8.01e-05	0.0001	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	6.55e-05	8.18e-05	CbGpPWpGaD
